Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review.

Current drug metabolism - 1 Mar 2014

Rollason Victoria, Samer Caroline Flora, Daali Youssef, Desmeules Jules Alexandre

Abstract excerpt

Non-steroidal anti-inflammatory drugs (NSAIDs) are the most frequently used drugs, either on prescription or over-thecounter (OTC). Their daily dosage is based on randomised controlled trials and an empirical clinical assessment of their efficacy and toxicity that allows dose adjustment. The individual response can however be altered by environmental and genetic pharmacokinetic and pharmacodynamic factors. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Cyclooxygenase 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclooxygenase 2

Share to Cytochrome P-450 Enzyme System

Share to OTC gene

Share to Genetic Variation

Share to Glucuronosyltransferase

Share to Treatment Outcome

Source

Identifiers

PMID: 24524667
DOI: 10.2174/1389200215666140202214454

Genes

OTC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review.PMID 24524667Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.Semantic proximity Read ↗

Pharmacogenomics of cyclooxygenases.Semantic proximity Read ↗

Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?Semantic proximity Read ↗

The pharmacogenetics of analgesiaSemantic proximity Read ↗

An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding.Semantic proximity Read ↗

Genetic basis of hypersensitivity reactions to nonsteroidal anti-inflammatory drugsSemantic proximity Read ↗

Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies.Semantic proximity Read ↗

Pharmacogenomics in aspirin intolerance.Semantic proximity Read ↗

Pharmacogenomics of Anti-Inflammatory Therapy: Toward Personalized Use of Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, and BiologicsSemantic proximity Read ↗

Pharmacogenetics of analgesics: toward the individualization of prescription.Semantic proximity Read ↗

[Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs].Semantic proximity Read ↗

Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.